Detailed information for compound 1788687

Basic information

Technical information
  • TDR Targets ID: 1788687
  • Name: [(2R,3S,4S,5R,6S)-6-(4-acetyl-2-methoxyphenox y)-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4- hydroxyphenyl)prop-2-enoate
  • MW: 474.457 | Formula: C24H26O10
  • H donors: 4 H acceptors: 6 LogP: 1.17 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(ccc1O[C@@H]1O[C@H](COC(=O)/C=C/c2ccc(cc2)O)[C@H]([C@@H]([C@H]1O)O)O)C(=O)C
  • InChi: 1S/C24H26O10/c1-13(25)15-6-9-17(18(11-15)31-2)33-24-23(30)22(29)21(28)19(34-24)12-32-20(27)10-5-14-3-7-16(26)8-4-14/h3-11,19,21-24,26,28-30H,12H2,1-2H3/b10-5+/t19-,21-,22+,23-,24-/m1/s1
  • InChiKey: ZZDJNPFVWSOKTO-TULNHCNLSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • [(2R,3S,4S,5R,6S)-6-(4-acetyl-2-methoxy-phenoxy)-3,4,5-trihydroxy-tetrahydropyran-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate
  • (E)-3-(4-hydroxyphenyl)prop-2-enoic acid [(2R,3S,4S,5R,6S)-6-(4-acetyl-2-methoxyphenoxy)-3,4,5-trihydroxy-2-tetrahydropyranyl]methyl ester
  • (E)-3-(4-hydroxyphenyl)acrylic acid [(2R,3S,4S,5R,6S)-6-(4-acetyl-2-methoxy-phenoxy)-3,4,5-trihydroxy-tetrahydropyran-2-yl]methyl ester
  • [(2R,3S,4S,5R,6S)-6-(4-ethanoyl-2-methoxy-phenoxy)-3,4,5-trihydroxy-oxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis adenylate cyclase type IX, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Loa Loa (eye worm) hypothetical protein 0.0026 0.0187 0.0211
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Loa Loa (eye worm) hypothetical protein 0.0033 0.0388 0.0438
Onchocerca volvulus 0.0054 0.0991 0.0928
Loa Loa (eye worm) CAMK/CAMKL/PASK protein kinase 0.0328 0.8855 1
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Entamoeba histolytica acyl-coA synthetase, putative 0.0026 0.0187 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis intestinal guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Plasmodium vivax acyl-CoA synthetase, putative 0.0019 0 0.5
Trichomonas vaginalis adenylate cyclase type IX, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase type VI, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0026 0.0187 1
Onchocerca volvulus 0.0328 0.8855 1
Mycobacterium ulcerans long-chain fatty-acid CoA ligase 0.0026 0.0187 1
Trichomonas vaginalis adenylate cyclase type vIII, putative 0.0033 0.0388 0.5
Mycobacterium ulcerans hypothetical protein 0.0026 0.0187 1
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Schistosoma mansoni cellular tumor antigen P53 0.0054 0.0991 1
Mycobacterium leprae Possible transporter protein 0.0033 0.0388 1
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0033 0.0388 0.5
Leishmania major 4-coumarate:coa ligase-like protein 0.0026 0.0187 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase type III, putative 0.0033 0.0388 0.5
Mycobacterium ulcerans acyl-CoA synthetase 0.0026 0.0187 1
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Loa Loa (eye worm) hypothetical protein 0.0026 0.0187 0.0211
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis hypothetical protein 0.0033 0.0388 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Mycobacterium ulcerans acyl-CoA synthetase 0.0026 0.0187 1
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0033 0.0388 0.5
Chlamydia trachomatis acylglycerophosphoethanolamine acyltransferase 0.0019 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0033 0.0388 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase type, putative 0.0033 0.0388 0.5
Trypanosoma brucei STE group serine/threonine-protein kinase, putative 0.0035 0.0452 0.5
Leishmania major 4-coumarate:coa ligase-like protein 0.0026 0.0187 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Leishmania major 4-coumarate:coa ligase-like protein 0.0026 0.0187 0.5
Trichomonas vaginalis adenylate cyclase type IX, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase beta 1 subunit, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0026 0.0187 1
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0033 0.0388 0.5
Mycobacterium tuberculosis Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) 0.0026 0.0187 1
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0033 0.0388 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0033 0.0388 0.5
Brugia malayi Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog 0.0033 0.0388 1
Loa Loa (eye worm) hypothetical protein 0.0054 0.0991 0.112
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Echinococcus multilocularis tumor protein p63 0.0368 1 1
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase beta 2 subunit, putative 0.0033 0.0388 0.5
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0033 0.0388 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase type III, putative 0.0033 0.0388 0.5
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase type IX, putative 0.0033 0.0388 0.5
Brugia malayi aryl hydrocarbon receptor nuclear translocator protein, putative 0.0033 0.0388 1
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Plasmodium falciparum acyl-CoA synthetase 0.0019 0 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylyl cyclase type V, putative 0.0033 0.0388 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase type, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Loa Loa (eye worm) hypothetical protein 0.0026 0.0187 0.0211
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0033 0.0388 0.5
Mycobacterium ulcerans long-chain-fatty-acid-CoA ligase 0.0026 0.0187 1
Mycobacterium ulcerans acyl-CoA synthetase 0.0026 0.0187 1
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Entamoeba histolytica acyl-CoA synthetase, putative 0.0026 0.0187 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0033 0.0388 0.5
Trichomonas vaginalis adenylate cyclase type, putative 0.0033 0.0388 0.5
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0033 0.0388 0.5
Entamoeba histolytica acyl-CoA synthetase, putative 0.0026 0.0187 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0388 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0033 0.0388 0.5
Mycobacterium ulcerans long-chain-fatty-acid--CoA ligase 0.0026 0.0187 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) > 25 uM Antimalarial activity against ring stage of Plasmodium falciparum 3D7 infected in erythrocytes assessed as [3H]-hypoxanthine incorporation after 48 hrs by liquid scintillation counting analysis ChEMBL. 24035096

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.